CardioVascular Dynamics gets 510(k) for new catheters:
This article was originally published in Clinica
Endosonics' subsidiary CardioVascular Dynamics has received US 510(k) clearance for four additional catheter models of its Focus small vessel angioplasty catheters. The Focus uses CVD's Focal expansion technology to perform PTA using low and high balloon inflation pressures with a single catheter. The FDA action will enable the company to market the catheters for peripheral vascular angioplasty applications in small vessels. Worldwide marketing will begin in 1996.
You may also be interested in...
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
The Swiss giant is hoping to get seven more approvals for its blockbuster immunology drug over the next 10 years.
Cadila has filed for approval of saroglitazar for NASH in India. The drug, which could emerge as the first medicine for the indication if approved, is already being used by a million Indian patients for diabetic dyslipidemia and hypertriglyceridemia.